Vivo studies demonstrated that specific deletion of Mfn2 in cardiomyocytes impaired mitochondrial fusion and modest cardiac hypertrophy (Papanicolaou et al., 2011). This evidence concerns the gene MFN2 and cardiac hypertrophy.